LTR Pharma Ltd (LTP) — Working Capital to Net Assets Ratio
LTR Pharma Ltd (LTP) has a Working Capital to Net Assets ratio of 96.2% as of December 2025. Working capital of AU$25.85 Million (current assets of AU$26.31 Million minus current liabilities of AU$457.81K) is measured against net assets of AU$26.86 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
LTR Pharma Ltd Working Capital to Net Assets (2021–2025)
This chart shows how LTR Pharma Ltd's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 96.2%, reflecting working capital of AU$25.85 Million against net assets of AU$26.86 Million AUD. Explore LTR Pharma Ltd (LTP) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Working Capital to Net Assets for LTR Pharma Ltd (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for LTR Pharma Ltd from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of LTR Pharma Ltd.
| Year | WC/NA Ratio | Working Capital (AUD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.6% | AU$31.37 Million | AU$31.51 Million | AU$32.07 Million | AU$700.57K | ▼ -0.4 pp |
| 2024 | 99.9% | AU$2.94 Million | AU$2.94 Million | AU$3.37 Million | AU$428.54K | ▲ +14.4 pp |
| 2023 | 85.5% | AU$1.77 Million | AU$2.07 Million | AU$1.79 Million | AU$21.26K | ▲ +1.9 pp |
| 2022 | 83.6% | AU$1.48 Million | AU$1.77 Million | AU$1.95 Million | AU$475.91K | ▼ -694.2 pp |
| 2021 | 777.8% | AU$-317.36K | AU$-40.80K | AU$146.14K | AU$463.50K | — |